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ABSTRACT: 
The use of Parathyroid Hormone (PTH) as bone anabolic is limited due to cost-benefit 
assessments. Preclinical studies evaluating the effects of PTH on bone have reported variable 
and often contradictory results. Here, we have applied a new approach using a combination of 
in-vivo longitudinal µCT, image processing techniques and finite element models to monitor 
early local changes in the whole tibia (divided in 40 compartments) and mechanical 
properties of female C57BL/6J mice treated with PTH 1-34, compared to controls. Compared 
with standard 3D bone morphometric analysis, our new approach allowed detection of much 
smaller and localised changes in bone mineral content (BMC) at very early time points (1 
week vs 3 weeks with standard methods) and showed that changes do not occur uniformly 
over time and across the anatomical space. Indeed, in the PTH treated mice, significant 
changes in BMC were observed in the medial and posterior sectors of the proximal tibia, a 
week after treatment, and in the medial sector of the tibia midshaft region a week later 
(p<0.05). By the third week, two thirds of the regions showed significantly higher values of 
BMC (p<0.05). The effect of PTH on bone regional volume is similar to that on BMC, but 
there is almost no effect of PTH on bone tissue mineral density. The differences in estimated 
mechanical properties became significant after three weeks of treatment (p<0.05). These 
results provide the first evidence of an early and localised PTH effect on murine bone, and 
show that our novel partitioning approach, compared to the standard evaluation protocol, 
allows a more precise quantification of bone changes following treatment, which would 
facilitate preclinical testing of novel mono- and/or combination therapies throughout the 
bone.  
 
KEY WORDS: PTH, bone remodeling, animal models, micro-CT, bone quantification. 
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1 Introduction 
Osteoporotic fractures are a major clinical problem that increases the mortality and 
morbidity of our ageing society [1, 2]. Despite being the only FDA approved anabolic drug 
for the treatment of osteoporosis [3], teriparatide (PTH 1-34) is recommended for use only as 
secondary line of intervention due to cost-benefit considerations. Therefore, finding ways to 
reduce teriparatide dosage while still retaining its positive effects is the focus of intense 
investigation [4]. 
Preclinical studies are useful tools to understand how this may be achieved. However, 
testing for the effect of parathyroid hormone (PTH) on bone in mono- or combination therapy 
has reported variable results in mice [5-8]. This is thought to be due to the cross-sectional 
design of the studies, which limits the power to detect meaningful differences, and to the way 
the 3D bone micro-architecture is analysed, by using sample regions (e.g. the proximal/distal 
region and/or the midshaft region of long bones), thus underrepresenting the response of the 
whole bone [9-11].  PTH has been shown to increase trabecular bone density and femoral 
strength measured by three-points bending mechanical testing in juvenile [12], young [13] 
and adult [14] mice.  This ex vivo approach allows only for comparison of mechanical 
properties between groups of different animals in standard cross-sectional designs, including 
the intrinsic inter-subject variability and limiting the power of detecting small longitudinal 
changes in the same animals. Furthermore, three-points bending tests are affected by 
experimental artefacts [15] and are scarcely informative of the changes in bone strength due 
to changes in the cortical and trabecular bone properties in different regions of the bone.  
In vivo imaging techniques can be used to non-invasively analyse the same tissues of the 
same mice longitudinally, reducing the measurement variability due to inter-subject 
differences [16]. In particular, the combination of in vivo micro computed tomography (µCT) 
and image registration improve the measurement of bone properties by reducing 
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measurements uncertainties [17]. Recently this approach has been used to study in mice 
models the effect of interventions and/or mechanical loading on bone remodelling in the 
trabecular centrum of the caudal vertebrae [18-20], in the proximal tibia [21-23] or in the 
tibia midshaft [24, 25]. However, little is known about early spatiotemporal effects of PTH 
on the morphological and densitometric properties of the whole mice bones.  The three-
dimensional µCT images of the mouse tibia can be converted into finite element (FE) models 
for non-invasive estimation of its mechanical properties [26, 27]. In vivo µCT-based FE 
models of bone portions have been used to investigate the relationship between bone 
remodeling and mechanical stimuli in para-physiological loading conditions [19, 28] and to 
study bone healing [29]. To the authorsÕ knowledge no studies have used the in vivo µCT-
based FE models to reveal longitudinal changes in the whole tibia mechanical properties and 
their relations with the spatiotemporal changes of bone morphological and densitometric 
properties. This would be fundamental to understand if the pre-clinically tested intervention 
would be effective in improving the bone competence of resisting fractures, which is the final 
clinical goal of anti-osteoporosis treatments.  
The aim of this study is to quantify longitudinal effects of PTH on the properties on the 
tibia of female C57BL/6J mice by using a combination of in vivo µCT imaging, image 
processing and finite element analysis. 
 
2 Material and Methods: 
2.1 Animals and treatment 
Ten 13-weeks-old female C57BL/6J mice were purchased from Harlan Laboratories 
(Bicester, UK). They were housed in the University of SheffieldÕs Biological Services Unit 
with a twelve-hour light/dark cycle at 22¡C and free access to food and water. All the 
procedures complied with the UK Animals (Scientific Procedures) Act 1986 and were 
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reviewed and approved by the local Research Ethics Committee of the University of 
Sheffield (Sheffield, UK). At 18 weeks of age, mice (n=5/group) received a daily i.p. 
injection of either PTH (hPTH 1-34, Bachem, Bubendorf, Switzerland) at 100 ng/g/day 7 
days a week (ÒWT+PTHÓ group) or vehicle (ÒWTÓ group). PTH was prepared in 1% acetic 
acid and 2% heat inactivated mouse serum in HBSS (HankÕs Balanced Salt Solution, 
Gibco¨). The treatment was given until the age of 22 weeks (end of the experiment).  
 
2.2 In-vivo µCT imaging 
The whole right tibia of the mice was imaged using the Scanco in-vivo µCT (vivaCT 80, 
Scanco Medical, Bruettisellen, Switzerland). A baseline scan was performed at 14 weeks of 
age, then weekly follow up scans starting the second week after the initial scan, for seven 
weeks (Figure 1). The scanner was operated at 55 keV, 145 µA, 32 mm FOV, 1500/750 
samples/projections, 200ms integration time and a nominal isotropic image voxel size of 10.4 
µm. A third-order polynomial beam hardening correction algorithm provided by the 
manufacturer, determined using the 1200 mg HA/cm
3
 wedge phantom, was applied to all the 
scans. The image grey values were then converted into HA-equivalent BMD values by means 
of the calibration law suggested by the manufacturer and based on weekly quality check 
performed with a five-rod densitometric calibration phantom. 
As in vivo µCT imaging is based on ionising radiation, there is an effect on the 
biological response of the imaged animal, which may affect the outcomes of the study. 
Taking into account this effect, we used the same scanning procedure for both groups at each 
time step and we reported data normalized for the baseline scans.  The chosen scanning 
protocol induced 513 mGy dose to the mouse. Previous studies on C57BL/6J mice reported 
that repeated scans inducing 776 mGy affect significantly only trabecular bone and scans 
inducing 434 mGy were found not to affect cortical nor trabecular parameters [30]. 
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Therefore, in order to evaluate the radiation effect with our scanning protocol, at the end of 
the longitudinal study we compared the bone mineral content in the scanned and the non-
irradiated contra-lateral tibiae.  
 
2.3 Standard 3D morphometric analysis 
For trabecular bone analysis, a region of 1.0 mm height was chosen 0.2 mm below the 
growth plate as previously described [31].For cortical bone analysis, a region of 1.0 mm 
height was chosen in the tibia midshaft [31]. Regions of interest for each compartment were 
manually marked and 3D bone parameters were generated, namely: trabecular bone volume 
fraction (BV/TV), number (Tb.N), separation (Tb.Sp) and thickness (Tb.Th) and average 
cortical thickness (Ct.Th).The analyses were performed with the software provided by the 
manufacturer of the µCT (V6.5-3, Scanco Medical, Bruettisellen, Switzerland). 
 
2.4 Image processing and 4D analyses analysis 
Image processing was performed as previously described [31]. Briefly, rigid registration 
was applied to align tibiae along the longitudinal axis and to achieve correct rotation around 
this axis. For the registration, the tibia from the baseline scan was taken as the reference [27]. 
The tibiae from the following scans and from other mice were rigidly registered to the tibia of 
the baseline using a Quasi-Newton optimizer and the Euclidean distance as the similarity 
measure (Amira 5.4.3, FEI Visualization Sciences Group, France).  Afterwards, the tibiae 
were divided in different regions and the bone properties in each region were tracked in time. 
In particular, after the image transformation, the tibial length (L) was measured from tibial 
most proximal voxel to the most distal voxel and a region of 80% of L was cropped out 
starting from the area below the proximal growth plate (Matlab, 2015a, The Mathworks, Inc. 
USA). Then, the obtained volume of interest (VOI) was partitioned into compartments 
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(Figure 2) using an in-house developed Matlab code. In the tibial longitudinal (proximal-
distal) direction, the VOI was divided into ten regions with the same length to minimise the 
effect of tibial growth on the measured data. Each tibial transverse (x-y) section was then 
divided into four sectors (anterior, medial, posterior and lateral sectors) by two straight 
crossing lines passing through the centre of mass of each slice (Figure 2). This step was 
implemented in order to account for the small (but still significant) growth of the tibia after 
week 14 which would affect dramatically the measurement of bone changes if a method 
based on rigid registration and Boolean operation would be used [31, 32]. Our approach 
implicitly assumes that after week 14 the growth can be considered affine, with homogeneous 
growth along the longitudinal direction. The greyscale VOI datasets were smoothed with a 
Gaussian filter (convolution kernel [3 3 3], standard deviation = 0.65) and then binarised 
using 25.5% of the maximal greyscale value in order to isolate bone voxels [33] and to 
reduce the effect of the image noise. The bone mask was then obtained from the binarised 
images. The bone mineral content (BMC) and bone volume (BV) were calculated as the sum 
of bone mineral (obtained from the greyscale images) and bone volume over the total and 
regional masked bone regions. The regional bone tissue mineral density (TMD) was 
calculated as the mean mineral density within the masked bone regions.    
Changes of tibial bone parameters (BP), including BMC, BV and TMD in each 
compartment were represented as the mean relative percentage difference between the 
intervention (WT+PTH) and the control (WT) groups. First, for each week (j), in each 
compartment, the mean changes in BP relative to the baseline values for the control (!!!) 
and PTH treated (!!!) groups were calculated as below:  
!!! !
��!!!!!��!!!��
!!
!!!
!!
           (1) 
!!! !
��!!!!!��!!!��
!!
!!!
!!
          (2) 
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where, n1 and n2 are the numbers of mice in control (BP1) and PTH (BP2) groups;  j 
represents the week index and i represents the mouse number index. 
Then for each week, in each compartment, the difference between the control (!!!! and 
PTH treated groups (!!!! normalized to the average BP of the control at that week, which is 
defined as the mean relative percentage difference (��!!), was calculated as below.  
��!! !
!!! ! !!!
���!
!���        (3) 
where,  
���! !
��!!!!
!!
!!!
!!
 
The precision error for this procedure was found to be less than 3.0% [31], therefore, 
only changes in BMC and BV lower than -3.0% or greater than +3.0% will be considered for 
interpretation. 
 
 
2.5 Finite element models 
Subject-specific micro-FE (µFE) models of each tibia at each time point were generated. 
A connectivity filter was used to clean the binarized VOI image datasets from all 
unconnected bone islands (by keeping a face-to-face connectivity). The resulting dataset was 
directly converted into 8-node hexahedral element mesh using a well-established procedure 
recently validated for trabecular bone samples [34]. Bone was modelled as homogenous, 
isotropic, and linear elastic, with a module of elasticity of 14.8 GPa, and PoissonÕs ratio of 
0.3 [35, 36].  The tibia compressive stiffness and failure load were calculated by fully 
constraining the proximal part of the VOI and by applying a displacement of 0.05mm along 
the tibial longitudinal axis to the distal side of the VOI. The tibiae were aligned using the 
image rigid registration, which assured that the tibiae were tested in the same loading 
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condition among animals and time points. The compressive stiffness was computed as the 
total reaction forces divided by the applied displacement.  
The resulting linear µFE models were solved (Ansys, Release 14.0.3, ANSYS, Inc.) on 
a workstation (Intel Xeon E-5-2670. 2.60 GHz, 256 GB RAM) in approximately 75 minutes. 
 
2.6 Statistical analysis 
The standard 3D morphological parameters (BV/TV, Tb.N, Tb.Sp, Tb.Th and Ct.Th), 
the regional BMC, BV and TMD, total BMC, FE predicted stiffness and failure load were 
analysed using the Analysis of Covariance (ANCOVA) (adjust for the baseline values at 
week 14) to test the effect of PTH intervention. Analysis was performed in R software 
(https://www.r-project.org/). Data are presented as mean ± standard deviation (SD) unless 
otherwise specified, and p values <0.05 are considered statistically significant. Linear 
regression equations and the coefficients of determination (R
2
) were computed for 
relationships between tibial BMC and stiffness calculated with the FE models.  
 
3 Results 
3.1. Effect of irradiation on BMC 
The total BMC measured at week 22 culling the animals on the non-irradiated tibia was 
lower than that measured on the irradiated tibia. Similar differences between non-irradiated 
and irradiated tibiae were found for both PTH intervention (WT+PTH) and control (WT) 
groups (5.8±1.9%, range 3.7-8.0% for control group; 5.1±0.9%, range 3.9-6.1% for PTH 
intervention group). Therefore, considering that similar differences were found for both 
intervention and vehicle groups we believe that our approach is reliable for evaluating the 
changes induced by PTH. 
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3.2. Effect of PTH treatment on bone morphometric and densitometric properties 
The standard 3D analysis revealed a significantly higher midshaft Ct.Th (p<0.0001) in 
response to PTH three weeks after treatment. Trabecular BV/TV, Tb.Th and Tb.N did not 
significantly change following PTH treatment (Table1). 
The spatiotemporal analysis showed significant effects of treatment on BMC changes 
with respect to baseline, already after one week, localised in the most proximal sub volumes 
of the tibia (C01: + 7% vs WT; p<0.05 for posterior sector and + 9% vs WT; p<0.05 for 
medial sector). After two weeks of treatment, this effect is extended to other regions of the 
metaphysis and towards the diaphysis (anterior sectors: +11%, p<0.01 for C01; +8%, p<0.05 
for C02; posterior sectors: +9%, p<0.05 for C01 and +10%, p<0.01 for C02; medial sectors: 
+9%, p<0.05 for C01; +11%, p<0.05 for C04; +9%, p<0.05 for C05). By the 3
rd
 week of 
treatment, most of the sectors (34 out of 40) showed significant anabolic effect of PTH 
(ranging from +7% to +24%; p<0.05); which reached all sectors but two (in the distal portion 
of the lateral compartment, p>0.05) by the end of the experiment (Figure 3).  The 95% 
confidence intervals are reported in the supporting material (Supplemental Table S1 and 
Supplemental Table S2). The spatiotemporal analysis also showed the effect of PTH on tibial 
regional BV is very similar to that on BMC (Supplemental Figure S1) and there is no effect 
of PTH on tibial regional TMD (Figure 4).   
 
3.4. Tibial stiffness, total BMC and their correlations 
In both control and PTH intervention groups, the normalized total BMC and the 
normalized FE predicted stiffness increased from baseline values. The increase of both 
properties in the PTH intervention group after three weeks (week 21) of treatment were 
higher than those measured for the control group. The values normalized with respect to the 
baseline of the PTH intervention and control groups were 42.3±5.7% vs 25.9±6.7% for total 
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BMC and 24.3±5.4% vs 14.1±1.9% for FE predicted stiffness (both p<0.05, Figure 5). Larger 
differences between control and PTH intervention groups were found after four weeks (week 
22) of treatment (48.7±6.2% vs 27.9±5.9% for total BMC and 30.4±6.4% vs 13.4±3.3% for 
FE predicted stiffness, respectively; both p<0.01, Figure 5). 
The FE predicted tibial stiffness was highly linearly correlated with tibial total BMC for 
both pooled data (R
2
 equal to 0.88) and data separated between PTH intervention (R
2
 equal to 
0.92) and vehicle (R
2
 equal to 0.81) groups ( Figure 6).  
 
4 Discussion 
In this study, we have investigated the longitudinal effects of PTH on the morphometric 
(BT/TV, Tb.N, Tb.Sp, Tb.Th, Ct.Th and BV), densitometric (BMC and TMD) and 
mechanical properties (stiffness and failure load) of the tibia of female C57BL/6J mice.  
Our data revealed early localised BMC changes following PTH treatment, which 
could not be detected using the standard morphometric analysis restricted to small trabecular 
and cortical regions of interest. This is probably due to the more comprehensive and detailed 
spatiotemporal measurements (performed with our approach) over the whole tibia, the 
information of which can hardly be provided by the standard morphometric analysis.  Indeed, 
this anabolic statistically significant effect started in the most proximal region of the tibia at 
the posterior and medial sectors, progressively spreading in the proximal-distal direction and 
becoming significant in most compartments analysed by the third week of treatment. The 
spatiotemporal data on BMC, BV and TMD revealed that effect of PTH on BMC was mainly 
due to the changes in bone geometry and bone TMD was not affected by PTH treatment. To 
our knowledge, this is the first detailed spatiotemporal description of the effect of PTH on the 
whole mouse tibia. Detecting this level of details was made possible by improving our 
methodology in two main areas. Firstly, the longitudinal design made possible by the in-vivo 
12 
 
µCT imaging, combined with image registration, enabled us to follow each animal over time, 
and improved the precision of our measurements [17]. Secondly, in the spatial partitioning 
method, the size of the compartment was optimised to maximise the reproducibility of the 
measurements, while retaining an excellent description of the changes across the tibia 
anatomical space [31]. Our previous reproducibility study [31] showed measurements over 40 
compartments of mouse tibia (10 longitudinal sections) have a good reproducibility, which 
implies performing measurements on single slices (and normalised for length) would provide 
large errors due to the potential differences between an assumed affine growth and a real one. 
These methodological improvements contributed to a substantial reduction of the variance 
and a detailed mapping of spatiotemporal bone changes, making it possible to detect smaller 
and earlier effects, compared to standard 3D bone morphometric analysis. In addition, our 
partitioning method allows researcher to make comparisons even in young mice, where the 
changes in length and diameter in long bones due to growth are significant, as our 
compartments scale with bone growth [31].  The spatially uneven response of bone to PTH 
raises interesting hypotheses. PTH is a known vasorelaxant and its ostoanabolic activities 
have been linked to this property [38].  Moreover, the location of Nestin+ mesenchymal stem 
cells, progenitors of osteoblasts, is around arterioles in areas of higher oxygen concentration 
[39], which are associated with increased osteoblast function and arteriolar vascularization 
has been detected in the metaphysis [40]. The observed anabolic effect may therefore be 
positively associated with higher arterial vascularization. Alternatively, PTH may be 
increasing bone formation in areas with high biomechanical stimuli. Indeed, there is a 
growing interest in providing mechanistic insights into the primary and combined effects of 
PTH and biomechanical stimuli on bone [41, 42].  However, because simple loading 
conditions were applied in the present study, the correlation between mechanical stimuli and 
bone changes may not be able to properly highlight the mechanoregulation mechanism. 
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Further investigations, including estimations of physiological loading which the mouse is 
subjected to during daily activities, controlled in vivo mechanical loading [43], and analyses 
of micro-damage in vivo, are required to understand what is the main mechanism (e.g. micro-
damage or high strain energy density) associated to the efficacy of the PTH. A detailed 
mechanistic understanding of the primary effect of PTH on bone may lead to improved 
protocols of administration alone or in combination with mechanical stimulation. 
The FE analysis revealed an increase in the bone stiffness with time for both 
intervention and control groups. The increase in bone stiffness in the intervention group was 
significant only after three weeks of treatment, following similar trends as shown by the total 
BMC. The difference is probably related to the anabolic effect of PTH in most regions after 
week 21, while the significant increase in the BMC of the most proximal compartments after 
one or two weeks of treatment was not sufficient to improve the bone mechanical response, at 
least in the simulated axial compression. The regression analysis showed that the FE 
predicted stiffness was highly linearly correlated with tibial total BMC. This could be due to 
the high contribution of cortical thickness (and therefore BMC) in the midshaft in resisting 
the simulated loading condition. However, it should be noted that the prediction of bone 
mechanical behaviour from bone total BMC is not trivial and depends on the complex bone 
geometry, microarchitecture, density distribution and loading scenario. The mechanistic 
modeling of bone deformation from FE models provides a more comprehensive 
understanding on how bone deforms under loading and an appropriate estimation of tibial 
stiffness.  
There are some limitations related to this study. First, every invasive measurement 
inevitably interferes with the experiment; in particular for ionising radiations, the current 
thinking is that there will always be a non-null probability of biological effects, no matter 
how small the dose, although the probability decrease linearly as the dose decreases [44].   
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Therefore, the discussion should be focused on how big such effects are, and how much they 
affect our conclusions. The comparison with the contralateral, non-irradiated tibia confirmed 
that the repeated irradiation increased the BMC content by 5% on average, and produced 
similar effect for both PTH-treated and vehicle-treated mice.  What this experiment cannot 
ensure is that the spatiotemporal patterns we observed in term of PTH effect are not altered 
by the irradiation.  This can be confirmed only if we find similar patterns also when 
significantly lower radiation dose is used; to the purpose, we are currently developing novel 
scanning protocols that reduce the radiation dose while preserving the precision of the 
measurements. Second, the protocol we used to cope with the residual skeletal growth makes 
possible to monitor the changes in BMC only as average value within a set of 40 relatively 
coarse compartments, much coarser than what the theoretical spatial resolution of the images 
would allow.  In theory more sophisticated registration techniques such as full elastic 
registration [45] could provide a mapping of BMC changes with a 10 microns resolution; 
however, we first need to demonstrate that the errors produced by the registration and the 
associated image interpolation do not induce precision errors much larger than those obtained 
with the current method.  Third, linear specimen-specific FE models based on a Cartesian 
mesh have been used to predict the effect of the PTH on the bone stiffness. While we have 
recently shown for the first time that this µFE approach applied to bovine and human 
trabecular bone can predict well the distribution of local displacements compared to digital 
volume correlation measurements [34], the FE models could be further refined and improved 
by using a smooth tetrahedral mesh, and by implementing material heterogeneities and 
nonlinearities. Fourth, in this study, the PTH treatment was performed on healthy mature 
mice while it may be relevant to test a similar approach on old or ovariectomised mice. 
However, the main goal of this study was to demonstrate the potential of the spatiotemporal 
analysis and in the future we will test the approach on different animal models.  Last, in this 
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study we have focused on the effect of PTH on the BMC, TMD and BV changes over time 
because these parameters are simple and highly reproducible [31]. However, this method can 
be extended to measure other important parameters (e.g. cross-sectional area, moment of 
area, cortical thickness) in the different sub-regions [10]. 
In conclusion, we showed that comprehensive analyses of the whole bone provide 
detailed spatiotemporal characterization of changes in the morphological, densitometric and 
mechanical properties of the mouse tibia following PTH treatment. The same approach can 
be used to generate new hypotheses on mechanisms of action of current and future 
interventions, which would help to design more effective protocols of administration. 
 
Declare of conflict of interest  
The authors report no conflict of interest. 
 
Funding sources 
This work was funded by the UK National Centre for the Replacement, Refinement and 
Reduction of Animals in Research (NC3Rs) [grant number NC/K000780/1], the Engineering 
and Physical Sciences Research Council (EPSRC) Frontier Multisim Grant [grant number 
EP/K03877X/1], the Chinese Fundamental Research Funds for the Central Universities [grant 
number DUT15RC(3)130] and the Centre of Integrated Research into Musculoskeletal 
Ageing (CIMA). 
 
Acknowledgments 
The authors thank Anne CM Fowles and Mark Kinch for technical assistance and Peter Laud, 
of the Statistical Service Unit of the University of Sheffield, for his support with the 
statistical analyses. The protocol to prepare the PTH solution was kindly provided by Prof. 
16 
 
FerrariÕs group. Researchers are welcomed to contact the corresponding author who will 
share the data used in this study. 
 
References 
 
[1] Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporosis International. 
2005;16 Suppl 2:S3-7. 
[2] Kanis JA, Johnell O. Requirements for DXA for the management of osteoporosis in 
Europe. Osteoporosis International. 2005;16:229-38. Epub 2004 Dec 24. 
[3] Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of 
parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women 
with osteoporosis. N Engl J Med. 2001;344:1434-41. 
[4] Li W, Chen W, Lin Y. The Efficacy of Parathyroid Hormone Analogues in Combination 
With Bisphosphonates for the Treatment of Osteoporosis: A Meta-Analysis of Randomized 
Controlled Trials. Medicine. 2015;94:e1156. 
[5] Bouxsein ML, Pierroz DD, Glatt V, Goddard DS, Cavat F, Rizzoli R, et al. beta-Arrestin2 
regulates the differential response of cortical and trabecular bone to intermittent PTH in 
female mice. J Bone Miner Res. 2005;20:635-43. 
[6] Ferrari SL, Pierroz DD, Glatt V, Goddard DS, Bianchi EN, Lin FT, et al. Bone response 
to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. 
Endocrinology. 2005;146:1854-62. 
[7] Pierroz DD, Bonnet N, Baldock PA, Ominsky MS, Stolina M, Kostenuik PJ, et al. Are 
osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of 
intermittent parathyroid hormone with denosumab or alendronate in knock-in mice 
expressing humanized RANKL. J Biol Chem. 2010;285:28164-73. 
[8] Wu X, Pang L, Lei W, Lu W, Li J, Li Z, et al. Inhibition of Sca-1-positive skeletal stem 
cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone 
remodeling. Cell stem cell. 2010;7:571-80. 
[9] Altman AR, Tseng WJ, de Bakker CM, Huh BK, Chandra A, Qin L, et al. A closer look at 
the immediate trabecula response to combined parathyroid hormone and alendronate 
treatment. Bone. 2014;61:149-57. 
[10] Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. 
Guidelines for assessment of bone microstructure in rodents using micro-computed 
tomography. Journal of Bone and Mineral Research. 2010;25:1468-86. 
[11] de Bakker CM, Altman AR, Tseng WJ, Tribble MB, Li C, Chandra A, et al. muCT-
based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses 
of bone resorption and formation to PTH and alendronate combination therapy. Bone. 
2015;73:198-207. 
[12] Bartlow CM, Oest ME, Mann KA, Zimmerman ND, Butt BB, Damron TA. PTH(1-34) 
and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and 
morphology. J Orthop Res. 2016. 
[13] Vrahnas C, Pearson TA, Brunt AR, Forwood MR, Bambery KR, Tobin MJ, et al. 
Anabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral 
composition or maturation. Bone. 2016;93:146-54. 
[14] Johnston S, Andrews S, Shen V, Cosman F, Lindsay R, Dempster DW, et al. The effects 
of combination of alendronate and human parathyroid hormone(1-34) on bone strength are 
17 
 
synergistic in the lumbar vertebra and additive in the femur of C57BL/6J mice. 
Endocrinology. 2007;148:4466-74. 
[15] Wallace RJ, Pankaj P, Simpson AH. Major source of error when calculating bone 
mechanical properties. J Bone Miner Res. 2014;29:2697. 
[16] Dall'Ara E, Boudiffa M, Taylor C, Schug D, Fiegle E, Kennerley AJ, et al. Longitudinal 
imaging of the ageing mouse. Mechanisms of ageing and development. 2016. 
[17] Campbell GM, Tiwari S, Grundmann F, Purcz N, Schem C, Gluer CC. Three-
dimensional image registration improves the long-term precision of in vivo micro-computed 
tomographic measurements in anabolic and catabolic mouse models. Calcified Tissue 
International. 2014;94:282-92. 
[18] Lambers FM, Kuhn G, Schulte FA, Koch K, Muller R. Longitudinal assessment of in 
vivo bone dynamics in a mouse tail model of postmenopausal osteoporosis. Calcified Tissue 
International. 2012;90:108-19. 
[19] Levchuk A, Zwahlen A, Weigt C, Lambers FM, Badilatti SD, Schulte FA, et al. The 
Clinical Biomechanics Award 2012 - presented by the European Society of Biomechanics: 
large scale simulations of trabecular bone adaptation to loading and treatment. Clinical 
Biomechanics (Bristol, Avon). 2014;29:355-62. 
[20] Schulte FA, Lambers FM, Kuhn G, Muller R. In vivo micro-computed tomography 
allows direct three-dimensional quantification of both bone formation and bone resorption 
parameters using time-lapsed imaging. Bone. 2011;48:433-42. 
[21] Ausk BJ, Huber P, Srinivasan S, Bain SD, Kwon RY, McNamara EA, et al. Metaphyseal 
and diaphyseal bone loss in the tibia following transient muscle paralysis are 
spatiotemporally distinct resorption events. Bone. 2013;57:413-22. 
[22] Buie HR, Moore CP, Boyd SK. Postpubertal architectural developmental patterns differ 
between the L3 vertebra and proximal tibia in three inbred strains of mice. J Bone Miner Res. 
2008;23:2048-59. 
[23] Stadelmann VA, Bonnet N, Pioletti DP. Combined effects of zoledronate and 
mechanical stimulation on bone adaptation in an axially loaded mouse tibia. Clinical 
Biomechanics (Bristol, Avon). 2011;26:101-5. 
[24] Birkhold AI, Razi H, Weinkamer R, Duda GN, Checa S, Willie BM. Monitoring in vivo 
(re)modeling: a computational approach using 4D microCT data to quantify bone surface 
movements. Bone. 2015;75:210-21. 
[25] Birkhold AI, Razi H, Duda GN, Weinkamer R, Checa S, Willie BM. The influence of 
age on adaptive bone formation and bone resorption. Biomaterials. 2014;35:9290-301. 
[26] Pereira AF, Javaheri B, Pitsillides AA, Shefelbine SJ. Predicting cortical bone adaptation 
to axial loading in the mouse tibia. Journal of the Royal Society, Interface / the Royal 
Society. 2015;12:0590. 
[27] Razi H, Birkhold AI, Zaslansky P, Weinkamer R, Duda GN, Willie BM, et al. Skeletal 
maturity leads to a reduction in the strain magnitudes induced within the bone: a murine tibia 
study. Acta Biomater. 2015;13:301-10. 
[28] Razi H, Birkhold AI, Weinkamer R, Duda GN, Willie BM, Checa S. Aging Leads to a 
Dysregulation in Mechanically Driven Bone Formation and Resorption. J Bone Miner Res. 
2015;30:1864-73. 
[29] Casanova M, Herelle J, Thomas M, Softley R, Schindeler A, Little D, et al. Effect of 
combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus 
structure and composition. Bone. 2016;92:70-8. 
[30] Laperre K, Depypere M, van Gastel N, Torrekens S, Moermans K, Bogaerts R, et al. 
Development of micro-CT protocols for in vivo follow-up of mouse bone architecture 
without major radiation side effects. Bone. 2011;49:613-22. 
18 
 
[31] Lu Y, Boudiffa M, Dall'Ara E, Bellantuono I, Viceconti M. Development of a protocol 
to quantify local bone adaptation over space and time: Quantification of reproducibility. J 
Biomech. 2016;49:2095-9. 
[32] Lu Y, Boudiffa M, Dall'Ara E, Bellantuono I, Viceconti M. Evaluation of in-vivo 
measurement errors associated with micro-computed tomography scans by means of the bone 
surface distance approach. Med Eng Phys. 2015;37:1091-7. 
[33] Klinck J, Boyd SK. The magnitude and rate of bone loss in ovariectomized mice differs 
among inbred strains as determined by longitudinal in vivo micro-computed tomography. 
Calcified Tissue International. 2008;83:70-9. 
[34] Chen Y, DallÕAra E, Manda K, Sales E, Wallace R, Pankaj P, et al. Micro-CT based 
finite element models of cancellous bone predict accurately displacement once the boundary 
condition is well replicated: a validation study. Journal of the Mechanical Behavior of 
Biomedical Materials. 2017; 65: 644-651. 
[35] Vickerton P, Jarvis JC, Gallagher JA, Akhtar R, Sutherland H, Jeffery N. Morphological 
and histological adaptation of muscle and bone to loading induced by repetitive activation of 
muscle. Proceedings Biological sciences / The Royal Society. 2014;281:20140786. 
[36] Webster DJ, Morley PL, van Lenthe GH, Muller R. A novel in vivo mouse model for 
mechanically stimulated bone adaptation--a combined experimental and computational 
validation study. Comput Methods Biomech Biomed Engin. 2008;11:435-41. 
[37] Bayraktar HH, Keaveny TM. Mechanisms of uniformity of yield strains for trabecular 
bone. Journal of Biomechanics. 2004;37:1671-8. 
[38] Marenzana M, Arnett TR. The Key Role of the Blood Supply to Bone. Bone Res. 
2013;1:203-15. 
[39] Spencer JA, Ferraro F, Roussakis E, Klein A, Wu J, Runnels JM, et al. Direct 
measurement of local oxygen concentration in the bone marrow of live animals. Nature. 
2014;508:269-73. 
[40] Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis 
by a specific vessel subtype in bone. Nature. 2014;507:323-8. 
[41] Gardinier JD, Mohamed F, Kohn DH. PTH Signaling During Exercise Contributes to 
Bone Adaptation. J Bone Miner Res. 2015;30:1053-63. 
[42] Sugiyama T, Saxon LK, Zaman G, Moustafa A, Sunters A, Price JS, et al. Mechanical 
loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on 
trabecular and cortical bone in mice. Bone. 2008;43:238-48. 
[43] Birkhold AI, Razi H, Duda GN, Weinkamer R, Checa S, Willie BM. Mineralizing 
surface is the main target of mechanical stimulation independent of age: 3D dynamic in vivo 
morphometry. Bone. 2014;66:15-25. 
[44] Preston RJ. Update on linear non-threshold dose-response model and implications for 
diagnostic radiology procedures. Health Physics. 2008;95:541-6. 
[45] Dall'Ara E, Barber D, Viceconti M. About the inevitable compromise between spatial 
resolution and accuracy of strain measurement for bone tissue: a 3D zero-strain study. J 
Biomech. 2014;47:2956-63. 
  
 
 
 
 
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Overview of the experimental design. Scans were performed at week 14 and then 
weekly from week 16 to week 22. Starting from week 18, mice received a daily i.p. injection of 
PTH (ÒWT+PTHÓ group, 100ng/g/day) or vehicle (ÒWTÓ group) 7 days a week. 
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Figure 2: Schematic representation of the partitioning of the tibia into 40 compartments. The 
tibia from the baseline scan serves as reference (a) and the tibiae from the following scans(c) 
and from other mice are rigidly registered to it (d). After the image transformation, the tibial 
length (L) is measured and a region of 80% of L is cropped out starting from the area below 
the proximal growth plate. The tibia volume of interest (VOI)(e) was converted into subject-
specific finite element (FE) models (f) for the estimation of compressive. The bone mineral 
content was computed in 40 regions, after dividing the VOI into ten sections with the same 
length along the tibia longitudinal (proximal-distal) direction and dividing each section into 
four sectors (anterior, medial, posterior and lateral sectors) according to the centre of mass 
of each slice (g). 
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Figure 3: The spatiotemporal effect of PTH on tibial regional bone mineral content (BMC).  
Data are expressed as the weekly mean relative percentage difference of changes in BMC 
between the PTH and the control group for the 10 sub-divisions along the tibial axis, for each 
of the 4 anatomical positions (Lateral, Medial, Anterior and Posterior). Table colour code: 
The grey areas are values within our measurement error range, therefore with no significant 
changes. The red areas represent an anabolic effect. * p<0.05, ** p<0.01 vs WT. N= 5 mice. 
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Figure 4: The spatiotemporal effect of PTH on tibial regional bone tissue mineral volume 
(TMD). Data are expressed as the weekly mean relative percentage difference of changes in 
TMD between the PTH and the control group for the 40 compartments. Table colour code: 
The grey areas are values within our measurement error range, therefore with no significant 
changes. 
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Figure 5: Longitudinal effect of PTH intervention on total tibial BMC and FE predicted 
stiffness over the temporal scale. Data presented as mean standard deviations of the 
normalized data with respect to baseline (*p<0.05,**p<0.01). 
 
 
Figure 6: Linear regression analysis for predicted stiffness vs BMC for data pooled for both 
PTH intervention and vehicle groups (left) or separated (right; PTH intervention in full 
circles and bottom right equations; vehicle group in open circles and top left equations). 
   
